Adagene Inc.
NASDAQ:ADAGBiotechnology
+$0.13 today
- Market cap
- $68.52M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$0.47
Volume 1.30M
Average 0.21M
ADAG Long-term Investments
Investments the company intends to hold for more than a year.
Adagene Inc.NASDAQ: ADAG
Long-term Investments · Q4 FY2025 · quarter ended Dec 2025
Long-term investments remains negative
Q4 FY2025 long-term investments was $0, compared with $0 a year earlier.
Context
- Long-term investments amounted to 0.0% of total assets at the end of Q4 FY2025, unchanged from a year earlier.
- Long-term investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Long-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Long-term Investments vs competitors
How ADAG compares with its peers on the latest reported figures
- ADAG's Dec 2025 long-term investments of $0 is the 6th highest of the 9 companies compared; the peer median is $217.54K.
- Long-term investments amounts to 0.0% of total assets for ADAG, versus a peer median of 0.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $19.93M | — | +87.3% | 5.6% | |
| Mar 2026 | $5.03M | — | -0.0% | 2.5% | |
| Mar 2026 | $2.87M | — | — | 1.7% | |
| Mar 2026 | $399K | — | — | 3.4% | |
| Mar 2026 | $36.09K | +10.9% | -73.5% | 0.2% | |
| Dec 2025 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
OSTXOS Therapies Incorporated | Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding ADAG) | $217.54K | +10.9% | -0.0% | 0.9% | |
Competitors are the stored peer set for ADAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 174.39M | 143.76M | 109.93M | 85.19M | 74.52M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 7.51M | 619.43K | 222.03K | 8.31K | 17.35K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.49M | 3.78M | 2.7M | 527.71K | 1.2M |
| Total Current Assets | 185.95M | 149.32M | 113.44M | 87.78M | 77.38M |
| Property, Plant & Equipment (Net) | 3.49M | 2.97M | 2.2M | 1.41M | 862.91K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 69.28K | 109.57K | 84.89K | 103.5K | 25.22K |
| Total Non-current Assets | 3.56M | 3.08M | 2.29M | 1.51M | 888.13K |
| Total Assets | 189.51M | 152.4M | 115.73M | 89.27M | 78.26M |
| Account Payables | 3.32M | 3.67M | 3.09M | 4.24M | 2.88M |
| Short-term Debt | 4.5M | 13.62M | 8.4M | 17.79M | 4.98M |
| Tax Payables | 1.66M | 349.04K | 52.88K | 485.97K | 998.51K |
| Deferred Revenue | 5.5M | 15.11M | 0 | 0 | 3.46M |
| Other Current Liabilities | 11.62M | 111.92K | 119.75K | 56.27K | 232.24K |
| Total Current Liabilities | 29.82M | 55.08M | 31.46M | 38.18M | 25.17M |
| Long-term Debt | 2.99M | 14.15M | 13.54M | 417.34K | 1.14M |
| Deferred Tax Liabilities | 44.16K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 94.11K | 28.72K | 0 | 0 | 16.55M |
| Total Non-current Liabilities | 3.13M | 14.23M | 13.71M | 559.64K | 17.74M |
| Total Liabilities | 32.95M | 69.31M | 45.17M | 38.74M | 42.91M |
| Common Stock | 5.63K | 5.5K | 5.55K | 5.89K | 5.92K |
| Retained Earnings | (178.83M) | (258.81M) | (277.75M) | (311.18M) | (328.79M) |
| Accumulated OCI | (93.98K) | (849.31K) | (1.8M) | (526.9K) | (1.91M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 156.56M | 83.09M | 70.56M | 50.52M | 35.35M |
| Total Debt | 7.49M | 27.97M | 22.31M | 18.49M | 6.26M |
| Net Debt | (166.9M) | (115.79M) | (87.63M) | (66.7M) | (68.26M) |
Adagene Inc.
NASDAQ:ADAG
Intrinsic Alpha fair value
Locked
Current Price
$1.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.